Company: BOLT
Filing Date: 2025-03-24
Form Type: 10-K
Source: 0000950170-25-043873
Chunk: 195

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-03-24
Form: 10-K
Item: Item 1B
Chunk 195
---
    32.1*
     
    Certification of Principal Executive Officer  and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 

    X

    97.1+
     
    Incentive Compensation Recoupment Policy.
     
    10-K
     
    001-39988
     
    97.1
     
    3/21/2024

    101.INS
     
    Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

    X

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document

    X

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document

    X

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document

    X

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document

    X

    101.PRE
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document

    X

    104
     
    Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

    X

    +
    Indicates a management contract or compensatory plan, contract or arrangement. 

    #
    Portions of this exhibit have been omitted as the Registrant has determined that the omitted information (i) is not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed.

    *
    The certifications attached as Exhibit 32.1 and Exhibit 32.2 that accompany this Annual Report on Form 10-K, are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Bolt Biotherapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing. 

Item 16. Form 10-K Summary

None.

122

SIGNATURES 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 193